Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Radiopharmaceutical publicly funded in some provinces has fewer side effects than chemotherapy and can increase survival by ...

A group of senior gym-goers who got their prostates checked at roughly the same time were shocked to find almost half of them had early signs of cancer. The nine men meet regularly to work out at ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...

The treatment of prostate cancer in Uganda follows similar principles to those used worldwide, including surgery, radiation ...

A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study. Here is a roundup of March 2025 U.S. FDA ...

Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate ...

A Nigerian researcher, Dr Jerry Adeyemo, has identified alternative therapies that could help in the treatment of prostate ...

The phase 2a LEGION-100 trial seeks to evaluate the safety and effectiveness of the SYNC-T/SV-102 combination therapy for treating metastatic castration-resistant prostate cancer (mCRPC) and to ...

The widow of a stalwart WA farmer who took his life amid a battle with prostate cancer is calling on politicians to ‘stand up ...

This is a form of prostate cancer that has spread to other parts of the body and does not respond to standard hormone therapy, according to WebMD. It also has high levels of prostate-specific ...